KRPIA appoints Sanofi CEO Kay Bae as new chair
By | translator Kim, Jung-Ju
24.02.23 09:51:06
가나다라
0
Bae is the longest-serving CEO of a global pharmaceutical company, having led Sanofi for over ten years
“We will contribute to the advancement of healthcare in Korea in response to rapidly evolving systems and policies”
▲Kay Bae (Bae Kyung-eun) appointed as the new chair of KRPIA
The Korean Research-based Pharmaceutical Industry Association (KRPIA) announced on the 23rd that it has appointed Kay Bae (Bae Kyung-eun), Country Lead of Sanofi-Aventis Korea, as the 15th chair of KRPIA.
Bae served on the KRPIA board of directors in September 2013, and she has been a member of the vice-chair body, contributing to the growth of KRPIA.
Bae graduated from the College of Pharmacy at Seoul National University and received a master’s degree in global management from Aalto University School of Business.
Bae gained diverse experiences in the field, including positions as Global Head of Business Units, Head of Anticancer Drugs and Prescription Medicines,
(shm@dailypharm.com)
If you want to see the full article, please JOIN US (click)